| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $297K | — | +773.5% |
| Cost of Revenue | $109K | — | +336.0% |
| Gross Profit | $188K | — | +1988.9% |
| R&D Expense | $1.9M | — | -0.3% |
| SG&A Expense | $1.8M | — | +5.5% |
| Operating Income | -$3.5M | — | +2.5% |
| Pre-tax Income | $3.5M | — |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Short-term Investments | $11.3M | -25.3% | -48.2% |
| Accounts Receivable | $354K | -27.0% | +289.0% |
| Current Assets | $18.2M | -17.2% | -42.4% |
| Total Assets | $23.2M | -13.9% | -32.5% |
| Current Liabilities | $1.9M | -24.2% | -12.6% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.9M | — | -6.8% |
| Capital Expenditures | $448K | — | +132.1% |
| Investing Cash Flow | $3.5M | — | +1922.8% |
| Financing Cash Flow | -$36K | — | +20.0% |
| Free Cash Flow | -$4.4M | — | -13.0% |
| +206.8% |
| Net Income | -$3.5M | — | -5.7% |
| EPS (Basic) | -$2.07 | — | -3.0% |
| $4.2M |
| -15.1% |
| +73.9% |
| Stockholders' Equity | $19.1M | -13.6% | -40.5% |